PHASE 2 TRIAL RESULTS SHOW MESOBLAST CELL THERAPY HAS GREATEST CARDIOPROTECTIVE EFFECT IN PATIENTS WITH ADVANCED HEART FAILURE
http://www.stocknessmonster.com/news-item?S=MSB&E=ASX&N=430704
Don't think this is what the market was expecting
Add to My Watchlist
What is My Watchlist?